Recruiting NCT07421739

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Trial Parameters

Condition Choroidal Melanoma

Sponsor Aura Biosciences

Study Type OBSERVATIONAL

Phase N/A

Enrollment 15

Sex ALL

Min Age N/A

Max Age N/A

Start Date 2025-11-12

Completion 2028-08-15

All Conditions

Choroidal Melanoma Indeterminate Lesions Uveal Melanoma Ocular Melanoma

Interventions

Non-interventional, digital, patient-reported, real-world study

Brief Summary

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Eligibility Criteria

Inclusion Criteria: * Have enrolled in the Aura-sponsored clinical trial AU-011-301. * Access to a connected device (i.e., smartphone, laptop, or tablet) Exclusion Criteria: * None

Related Trials

NCT07421739

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subje

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE CHOROIDAL MELANOMA TRIALS